|
FDA Study May Help Sponsors Identify Potential for Serious Drug Reactions Sooner
CDER’s discovery of an autoimmune mechanism that leads to serious drug-induced adverse reactions in some patients taking HIV drug Ziagen could give drugmakers new methods to more quickly identify a drugs’ potential to cause severe reactions.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives